Video

Lars Edvinsson, MD

Publish date: April 13, 2016

Professor Edvinsson, whose pioneering work led to the understanding of how calcitonin gene-related peptide (CGRP) works in the trigeminal vascular system, discusses CGRP, migraine therapy, the blood-brain barrier, and the CGRP monoclonal antibodies currently in clinical trials.

 

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

Recommended Reading

High Headache Frequency Is More Likely During Perimenopause
MDedge Neurology
Electronic Screen Exposure Is Associated With Migraine in Young Adults
MDedge Neurology
Brian McGeeney, MD, MPH
MDedge Neurology
Bert Vargas, MD
MDedge Neurology
Gretchen Tietjen, MD
MDedge Neurology
Nerve Blocks May Provide Rapid Relief in Headache
MDedge Neurology
Haseeb Rahman, MD
MDedge Neurology
Headache Worsening After IV DHE May Not Predict Outcome of Chronic Migraine
MDedge Neurology
Intranasal Ketorolac Treats Migraine Effectively
MDedge Neurology
Giant-Cell Arteritis May Underlie New Headache
MDedge Neurology

Related Articles